Reduced Coinsurance for Certain Part B Rebatable Drugs
Applicable January 1 – March 31, 2024 President Biden’s historic Inflation Reduction Act requires drug companies to pay rebates to
Applicable January 1 – March 31, 2024 President Biden’s historic Inflation Reduction Act requires drug companies to pay rebates to
On Nov. 15, 2023, the Centers for Medicare and Medicaid Services (CMS) released the maximum cost-sharing limits for 2025 under
Rising health care costs will likely continue to impact employers in the foreseeable future. The introduction of biosimilar drugs as
Each year, the Kaiser Family Foundation conducts a survey to examine employer-sponsored health benefits trends. This document summarizes the main
News Brief: On September 21, 2023, the Biden administration announced an initiative that would prevent unpaid medical bills from impacting
News Brief: The American Academy of Actuaries (the Academy) published a public policy issue brief explaining a convergence of multiple